Arthritis treatment

Broadcast:

Story Details

There are more than 100 known types of arthritis, the most common being osteoarthritis (OA) and rheumatoid arthritis (RA).
It is estimated that nearly one in five Australians has arthritis ��" meaning more Australians have arthritis than any other national health priority condition.

In 2007, there were an estimated 3.85 million Australians with arthritis, including 2.4 million in the working age population (15-64 years).
By 2050, it is projected there will be 7 million Australians with arthritis - 23.9% of the projected population of 29.4 million.

In South Australia alone, over a quarter of a million people suffer from Arthritis. Over the next decade this figure is expected to jump by about 10 per cent.
In 2007, the total cost of arthritis to the Australian economy was estimated to be $23.9 billion.

It was estimated that almost half of this was due to the non-financial (burden of disease) costs, while health system costs including hospitals, pharmaceuticals and aged care account for 20%. A further 17% of total costs are productivity costs, reflecting the impact of arthritis on employment and workforce participation in Australia.

In 2007, the allocated health system expenditure associated with arthritis was $4.2 billion, approximately $1,100 per person with arthritis. $2 billion of this is estimated to have been allocated to OA, while health expenditure on RA was estimated at $422 million.

Health expenditure on arthritis exceeded that on coronary heart disease, depression, stroke, diabetes and asthma.

Other financial costs resulting from arthritis were estimated to be $7.6 billion in 2007. Over half of this was in productivity costs, reflecting the reduced employment rates and increased absenteeism that results from arthritic conditions.

For more information contact:
Arthritis SA
P: 08 8379 5711
Helpline: 1800 011 041
W: www.arthritissa.org.au
E: info@arthritissa.org.au

Rose-Hip Vital™ is suitable for Osteoarthritis and Rheumatoid Arthritis patients.

Approved claims:
Temporarily relieve the pain of Arthritis, Osteoarthritis and Rheumatism.
Relieve inflammation and joint swelling.
Increase joint mobility.
Improve sleep when affected by joint discomfort.
Improve Osteoarthritis symptoms in the hands.
Improve the symptoms of lower back pain.

About Galactolipid GOPO®:
The key active compound of the rosehip is the special patented, Galactolipid GOPO®, which is activated during a special drying process of the natural rosehip fruit plant and acts as a natural anti-inflammatory.

Rosehip and scientific studies:
Over 30 clinical and scientific studies have been done on Rosehip powder (Rosa Canina L.) internationally across a range of research organisations.

Most recently, a study published in the major medical journal Phytomedicine showed that Rosehip (Rosa Canina L.) may be beneficial for controlling some of the symptoms of Rheumatoid Arthritis.

Rose-Hip Vital™ is available across Australia from leading chemists, health food stores and specialty shops ��" and by toll free call to 1800 851 888 or online orders www.rosehipvital.com.au .

The RRP for Rose-Hip Vital™ capsules (250 capsules in each bottle) is $59.95.

Share